CERT
Companies
NASDAQ
Certara Inc.
Health Care
$10.57
-$0.08 (-0.75%)
Price Chart
Overview
About CERT
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Market Cap
$2.7B
Volume
16.8M
Avg. Volume
15.8M
P/E Ratio
18.67
Dividend Yield
0.00%
Employees
1.1K
Company Information
Risk & Correlation Analysis
Market Correlation
0.75
Moderate Correlation
Volatility
High (0.46)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CERT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.7B
Volume16.8M
P/E Ratio18.67
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
November 7, 2024Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025